Inhibition of platelet aggregation by nitric oxide donors improves with rest

Platelets

Volumn 14, Issue 6, 2003, Pages 347-349

  Broadley, Andrew J M ^a   Schmitt, Matthias ^b   Frenneaux, Michael P ^c  

^a TORBAY HOSPITAL   (United Kingdom)

^b Brit Cardiol Soc Research Fellow

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; NITRIC OXIDE; PADGEM PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CROSS LINKING; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MALE; PLATELET NITRATE RESPONSIVENESS; PRIORITY JOURNAL; REST; STANDARDIZATION; STRESS; SUPINE POSITION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

BLOOD PLATELETS; HUMANS; NITRATES; NITRIC OXIDE DONORS; NITROPRUSSIDE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 0346786502     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100310001603623     Document Type: Article

References (9)

1. Miyamoto S, Kawana H, Sakamoto T, Soejima H, Kajiwara I, Shimomura H et al. Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost 2003; 89: 681-6.
2. Michelson A D, Barnard M R, Kruger L A, Valeri C R, Furman M I. Circulating monocyte-platelet aggregated are a more sensitive marker of in vivo platelet activation than platelet P-selectin: studies in baboons, human coronary intervention, and human myocardial infarction. Circulation 2001; 104: 1533-7.
3. Garlichs C D, Eskafi S, Raaz D, Schmidt A, Ludwig J, Herrman M et al. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 2001; 86: 649-55.
4. Chakhtoura E Y, Shamoon F E, Haft J I, Obiedzinski G R, Cohen A J, Watson R M. Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings. Am J Cardiol 2000; 86: 835-9.
5. Chirkov Y Y, Holmes A S, Chirkova L P, Horowitz J D. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation 1999; 100: 129-34.
6. Sogo N, Magid K S, Shaw C A, Webb D J, Megson I L. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Biochem Biophys Res Commun 2000; 279: 412-9.
7. Broadley A J M, Gapper P, Schmitt M, Frenneaux M P. Supine rest reduces platelet activation and aggregation. Platelets 2003; 14: 3-7.
8. Chirkov Y Y, Holmes A S, Willoughby S R, Stewart S, Wuttke R D, Sage P R, Horowitz J D. Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. J Am Coll Cardiol 2001; 37: 1851-7.
9. Ellis G R, Anderson R A, Chirkov Y Y, Morris-Thurgood J, Jackson S K, Lewis M J et al. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol 2001; 37: 564-70.